| Clinical pharmacology considerations for the development of immune checkpoint inhibitors J Sheng, S Srivastava, K Sanghavi, Z Lu, BJ Schmidt, A Bello, M Gupta The Journal of Clinical Pharmacology 57, S26-S42, 2017 | 117 | 2017 |
| A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy M Feng, DE Smith, DP Normolle, JA Knol, CC Pan, E Ben-Josef, Z Lu, ... International Journal of Radiation Oncology* Biology* Physics 83 (5), 1441-1447, 2012 | 52 | 2012 |
| Pharmacokinetic profile of gilteritinib: a novel FLT-3 tyrosine kinase inhibitor AJ James, CC Smith, M Litzow, AE Perl, JK Altman, D Shepard, ... Clinical pharmacokinetics 59, 1273-1290, 2020 | 47 | 2020 |
| Population pharmacokinetics of immediate‐and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients Z Lu, P Bonate, J Keirns British journal of clinical pharmacology 85 (8), 1692-1703, 2019 | 31 | 2019 |
| Tumor growth dynamic modeling in oncology drug development and regulatory approval: past, present, and future opportunities N Al‐Huniti, Y Feng, J Yu, Z Lu, M Nagase, D Zhou, J Sheng CPT: pharmacometrics & systems pharmacology 9 (8), 419-427, 2020 | 20 | 2020 |
| Systems pharmacology and pharmacodynamics DE Mager, HHC Kimko Springer, 2016 | 15 | 2016 |
| Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo™ 3 J Chen, Z Lu, TS Lawrence, DE Smith Journal of Chromatography B 819 (1), 161-167, 2005 | 15 | 2005 |
| Drug-drug interaction potential of gilteritinib in healthy subjects and patients with relapsed/refractory acute myeloid leukemia M Levis, C Smith, M Litzow, A Perl, J Altman, A James, T Kadokura, ... Haematologica 102, 386, 2017 | 9 | 2017 |
| Population pharmacokinetic modelling to assess clinical drug–drug interaction between AZD 7325 and midazolam D Zhou, Z Lu, M Sunzel, H Xu, N Al‐Huniti Journal of clinical pharmacy and therapeutics 39 (4), 404-410, 2014 | 8 | 2014 |
| HPLC 法测定人血浆中法莫替丁浓度 卢铮， 陈济民 药物分析杂志 17 (2), 107-110, 1997 | 8 | 1997 |
| 鸦胆子油乳颗粒剂中油酸含量测定及其稳定性考察 孔令辉， 王淑丽， 卢铮， 姚崇舜， 陈济民， 黄菲 中草药 26 (2), 72-75, 1995 | 7 | 1995 |
| Pharmacokinetics of therapeutic proteins Z Lu, J Sheng, W Zhang Protein Therapeutics 2, 311-340, 2017 | 3 | 2017 |
| Applied pharmacokinetics in drug discovery and development H Yang, X Liu, A Chimalakonda, Z Lu, C Chen, F Lee, WC Shyu Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad, 177, 2010 | 3 | 2010 |
| 法莫替丁缓释片的生物利用度研究 曾环想， 陈静， 吴涛， 陈济民， 潘卫三， 卢铮 中国药学杂志 34 (8), 545-549, 1999 | 3 | 1999 |
| 法莫替丁缓释片的稳定性考察 卢铮， 潘卫三， 陈济民 中国药学杂志 34 (4), 278-278, 1999 | 3 | 1999 |
| Nonlinear mixed effects modeling in systems pharmacology PL Bonate, A Desai, A Rizwan, Z Lu, S Tannenbaum Systems Pharmacology and Pharmacodynamics, 255-276, 2016 | 2 | 2016 |
| Optimization of Amifostine Administration for Radioprotection. Z Lu | 2 | 2007 |
| 单剂量口服法莫替丁缓释片的药代动力学 卢铮， 陈济民 沈阳药科大学学报 15 (2), 79-81, 1998 | 2 | 1998 |
| Dose Finding in Single Dose Studies by Allometric Scaling Z Lu, R Kaspera, Y Naritomi, T Wang Drug Discovery and Evaluation: Methods in Clinical Pharmacology, 671-681, 2020 | 1 | 2020 |
| PHARMACOKINETIC-PHARMACODYNAMIC ANALYSIS OF MINIMAL RESIDUAL DISEASE WITH DATA AT BOUNDARY: GILTERITINIB A TYROSINE KINASE INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA. Z Lu, A James, J Hill, M Rosales, E Bahceci, P Bonate CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S62-S63, 2019 | 1 | 2019 |
